Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy

NCT07555301 is registered in ClinicalTrials.gov with Waid City Hospital, Zurich as lead sponsor.

NCT NCT07555301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07555301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy
Lead sponsor
Waid City Hospital, Zurich
Phase
Observational
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
December 31, 2029
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iga nephropathy (igan)